{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:16:13Z","timestamp":1773447373363,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by hepatic steatosis, inflammation and fibrosis, is becoming a global epidemic. However, the currently available effective clinical strategies remain limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted the choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) induced MASH mouse model to explore the effects of diphyllin on MASLD mice. We employ the targeted protein degradation technology applied for the discovery of compound\/protein-protein interaction to identify p65 as a potential target protein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We determine that diphyllin, a natural arylnaphthalene lignan lactone, is effective on MASLD, evidenced by the inhibition of hepatic lipid accumulation through promoting fatty acid oxidation in vivo and in vitro. To uncover the underlying mechanisms, we design and synthesis diphyllin-based protac and identify p65 as a potential target protein. Under p65 deficiency, the effects of diphyllin on lipid metabolism are blocked in vitro. As p65 as an antagonist of NRF2, diphyllin interacts with p65, leading to the induction of the NRF2 transcriptional activity and the enhancement of antioxidant capacity. When NFR2 is inhibited, the lowering effects of diphyllin on lipid is abolished.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our study presents diphyllin as a potential lead compound for MASLD therapy but also offers a novel approach for elucidating the mechanisms of action of natural products.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1567639","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:31:55Z","timestamp":1745818315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology"],"prefix":"10.3389","volume":"16","author":[{"given":"Xuejing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/ars.2015.6498","article-title":"Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 inflammasome via redox balance modulation","volume":"24","author":"Cai","year":"2016","journal-title":"Antioxid. Redox Signal"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.3390\/ijms231710055","article-title":"Autophagy dysregulation in metabolic associated fatty liver disease: a new therapeutic target","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jare.2023.10.014","article-title":"PROTAC derivatization of natural products for target identification and drug discovery: design of evodiamine-based PROTACs as novel REXO4 degraders","volume":"63","author":"Chen","year":"2024","journal-title":"J. Adv. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10001","DOI":"10.1073\/pnas.1207911109","article-title":"Cold but not sympathomimetics activates human brown adipose tissue in vivo","volume":"109","author":"Cypess","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1089130","DOI":"10.3389\/fphar.2022.1089130","article-title":"Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat-High fructose diet","volume":"13","author":"Garcia-Berumen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.3390\/molecules28237874","article-title":"Bioactivities and mechanisms of action of diphyllin and its derivatives: a comprehensive systematic review","volume":"28","author":"Hou","year":"2023","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/hsw\/hlaa003","article-title":"Police violence among adults diagnosed with mental disorders","volume":"45","author":"Jun","year":"2020","journal-title":"Health Soc. Work"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.2337\/db15-0242","article-title":"Inactivation of NF-\u03baB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP\/PKA pathway","volume":"64","author":"Ke","year":"2015","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"NASH field celebrates 'hurrah moment' with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mc.20465","article-title":"Molecular mechanisms of Nrf2-mediated antioxidant response","volume":"48","author":"Li","year":"2009","journal-title":"Mol. Carcinog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK","volume":"1783","author":"Liu","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.15212\/amm-2024-0010","article-title":"Application of PROTACs in target identification and target validation","volume":"3","author":"Liu","year":"2024","journal-title":"Acta Mater Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3892\/mmr.2016.5393","article-title":"Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-\u03baB in mice fed a high-fat diet","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17562848211031394","DOI":"10.1177\/17562848211031394","article-title":"Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation","volume":"14","author":"Middleton","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2308186","DOI":"10.1002\/advs.202308186","article-title":"Degradation-based protein profiling: a case study of celastrol","volume":"11","author":"Ni","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/ars.2020.8058","article-title":"Mitochondrial reactive oxygen species and mitophagy: a complex and nuanced relationship","volume":"34","author":"Schofield","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ejphar.2011.05.042","article-title":"Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma","volume":"667","author":"Shen","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/ars.2020.8024","article-title":"Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism","volume":"33","author":"Smolkova","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.aohep.2019.11.010","article-title":"NRF-2 and nonalcoholic fatty liver disease","volume":"19","author":"Solano-Urrusquieta","year":"2020","journal-title":"Ann. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1359\/jbmr.070613","article-title":"Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption","volume":"22","author":"Sorensen","year":"2007","journal-title":"J. Bone Min. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.molmet.2022.101566","article-title":"The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR","volume":"64","author":"Steffen","year":"2022","journal-title":"Mol. Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/antiox10071076","article-title":"Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): insights into the role of oxidative stress and antioxidant mechanism","volume":"10","author":"Tang","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41418-020-00668-w","article-title":"RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages","volume":"28","author":"Tao","year":"2021","journal-title":"Cell. Death Differ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep4.1618","article-title":"Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting","volume":"5","author":"Vieira Barbosa","year":"2021","journal-title":"Hepatol. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1016\/j.apsb.2022.07.007","article-title":"PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1039\/d3fo05111k","article-title":"A CDAHFD-induced mouse model mimicking human NASH in the metabolism of hepatic phosphatidylcholines and acyl carnitines","volume":"15","author":"Yang","year":"2024","journal-title":"Food Funct."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09168451.2018.1533804","article-title":"Recent advances in target identification of bioactive natural products","volume":"83","author":"Yoshida","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","article-title":"Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway","volume":"23","author":"Yu","year":"2011","journal-title":"Cell. Signal"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.3892\/mmr.2019.10787","article-title":"Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF-\u03baB\/I\u03baB\u03b1 pathways in the skeletal muscle of rats fed with a high fat diet","volume":"20","author":"Yu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/fimmu.2016.00538","article-title":"Critical roles of Kupffer cells in the pathogenesis of alcoholic liver disease: from basic science to clinical trials","volume":"7","author":"Zeng","year":"","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0149677","DOI":"10.1371\/journal.pone.0149677","article-title":"Blocking nuclear factor-kappa B protects against diet-induced hepatic steatosis and insulin resistance in mice","volume":"11","author":"Zeng","year":"","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.7150\/thno.29620","article-title":"p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/hep.26167","article-title":"Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C\/protein kinase G\/p65\/PPAR gamma coactivator 1 alpha pathway","volume":"57","author":"Zhou","year":"2013","journal-title":"Hepatology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1567639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:31:56Z","timestamp":1745818316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1567639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":49,"alternative-id":["10.3389\/fphar.2025.1567639"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1567639","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1567639"}}